Actively Recruiting
Effect of Nitrate Supplementation on Blood Pressure and Systemic Microvascular Function of Resistant Hypertensive Patients
Led by National Institute of Cardiology, Laranjeiras, Brazil · Updated on 2026-04-13
50
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying resistant arterial hypertension, a serious condition where high blood pressure remains elevated despite treatment. This condition increases risks for heart disease, stroke, kidney failure, and death. The study aims to evaluate if nitrate supplementation from beetroot powder can improve blood pressure and microvascular function in these patients. Beetroot powder is being considered as a simpler way to boost nitric oxide, which helps widen blood vessels. Participants are randomly assigned to one of two groups: one receives beetroot extract powder containing 400mg of nitrate daily, taken as 10 grams orally, while the other group receives a placebo supplement made of maltodextrin that matches the beetroot powder in color and flavor. The study is designed with quadruple masking to keep participants and staff unaware of group assignments. The main treatment period lasts 60 days. During the trial, participants will have their blood pressure monitored regularly to assess changes over the 60-day period. Researchers will track how blood pressure evolves and may evaluate systemic microvascular function. The total duration of participation corresponds to the treatment period, with safety and adherence monitored throughout. This study is led by the National Institute of Cardiology in Brazil and aims to provide clearer evidence on nitrate supplementation's effects in resistant hypertension.
CONDITIONS
Brief Title
Effect of Nitrate Supplementation on Blood Pressure and Microvascular Function of Resistant Hypertensive Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed resistant hypertension documented in medical records
- No changes in hypertension medications or doses within the last 30 days
- Age between 18 and 75 years
- Both genders included
You will not qualify if you...
- Presence of any type of cancer (neoplasms)
- Diagnosis of heart failure
- Current use of medications containing nitrate
- Patients who have undergone renal denervation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 60 days
Participants receive either beetroot extract or placebo supplementation orally daily to assess effects on blood pressure and microvascular function.
Daily supplementation with crossover design
Trial Site Locations
Total: 1 location
1
National Institute of Cardiology
Rio de Janeiro, Brazil, 21040-360
Actively Recruiting
Research Team
E
EDUARDO TIBIRICA, MD, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here